Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Alleviating Acute Lung Injury Induced by Lipopolysaccharide: Dayuan Yin Suppresses Inflammation and Oxidative Stress in Elderly Male Rats

Author(s): Lei Zhang*, Wei Zhu, Ze-peng Zhang and Yu Huang

Volume 28, Issue 5, 2025

Published on: 12 June, 2024

Page: [840 - 852] Pages: 13

DOI: 10.2174/0113862073294620240527102409

Price: $65

Abstract

Background: The occurrence of acute lung injury (ALI) caused by lipopolysaccharide (LPS) is prevalent and perilous among older individuals. Inflammation and oxidative stress are vital factors in the progression of ALI in this population. Dayuan Yin (DYY) is a classic Chinese herbal formula used for treating pulmonary diseases. Thereforethis situation can be well simulated by selecting suitable aged rats and induced by LPS, which is helpful to evaluate the role of DYY.

Objective: The objective of this study is to assess the therapeutic efficacy of DYY in reducing pulmonary inflammation and oxidative stress injury in aged rats induced by LPS.

Methods: In elderly male Sprague Dawley (SD) rats, the ALI model was induced by injecting LPS into the peritoneal cavity. The therapeutic effect of the DYY group was evaluated after 3 days of oral administration. Lung tissue damage was assessed using hematoxylin-eosin staining and the lung wet/dry (W/D) ratio. Inflammatory reaction in lung tissue was analyzed by counting inflammatory agents, measuring total protein (TP), and examining the concentration of inflammatory components in bronchoalveolar lavage fluid (BALF). Lung oxidative stress was assessed by measuring malondialdehyde (MDA), inducible nitric oxide synthase (iNOS), and superoxide dismutase (SOD) levels in BALF. The impact of DYY on the phosphorylation of PI3K, AKT, and NF-κBp65 protein was analyzed using Western Blot (WB).

Results: The administration of DYY exhibited a dose-dependent reduction in the severity of lung injury caused by LPS, leading to a reversal of the LPS-induced lung W/D ratio. Furthermore, DYY treatment resulted in decreased levels of leukocytes, eosinophils, neutrophils, macrophages, lymphocytes, and total protein in BALF. Additionally, DYY significantly inhibited the upregulation of Interleukin -6, Interleukin -10, and Interleukin -1β (IL-6, IL-10, IL-1β) as well as Tumor necrosis factor-α(TNF-α) induced by LPS (P<0.01). The lungs experienced oxidative stress due to LPS, leading to the production of MDA and iNOS, as well as a decrease in SOD activity. DYY reduced oxidative stress in the lungs and inhibited the activation of p-PI3K, p-Akt, and p-NF-κBp65, with a greater effect at higher doses.

Conclusion: In a dose-dependent manner, DYY suppresses the inflammatory response and oxidative stress in the lung tissue of elderly rats, thereby reducing ALI caused by LPS. This effect may be attributed to the inhibition of the PI3K/AKT/NF-κB pathway activation.

Keywords: DYY, LPS, acute lung injury, inflammation, oxidative stress, PI3K/AKT/NF-κB.

« Previous Next »
Graphical Abstract

[1]
Shaw, T.D.; McAuley, D.F.; O’Kane, C.M. Emerging drugs for treating the acute respiratory distress syndrome. Expert Opin. Emerg. Drugs, 2019, 24(1), 29-41.
[http://dx.doi.org/10.1080/14728214.2019.1591369] [PMID: 30841764]
[2]
Rubenfeld, G.D.; Caldwell, E.; Peabody, E.; Weaver, J.; Martin, D.P.; Neff, M.; Stern, E.J.; Hudson, L.D. Incidence and outcomes of acute lung injury. N. Engl. J. Med., 2005, 353(16), 1685-1693.
[http://dx.doi.org/10.1056/NEJMoa050333] [PMID: 16236739]
[3]
Butt, Y.; Kurdowska, A.; Allen, T.C. Acute lung injury:A clinical and molecular review. Arch. Pathol. Lab. Med., 2016, 140(4), 345-350.
[http://dx.doi.org/10.5858/arpa.2015-0519-RA] [PMID: 27028393]
[4]
Ding, Z.; Zhong, R.; Xia, T.; Yang, Y.; Xing, N.; Wang, W.; Wang, Y.; Yang, B.; Sun, X.; Shu, Z. Advances in research into the mechanisms of Chinese Materia Medica against acute lung injury. Biomed. Pharmacother., 2020, 122, 109706.
[http://dx.doi.org/10.1016/j.biopha.2019.109706] [PMID: 31918277]
[5]
Zhu, Y.; Luo, L.; Zhang, M.; Song, X.; Wang, P.; Zhang, H.; Zhang, J.; Liu, D. Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway. J. Ethnopharmacol., 2023, 301, 115833.
[http://dx.doi.org/10.1016/j.jep.2022.115833] [PMID: 36252879]
[6]
Diao, Y.; Ding, Q.; Xu, G.; Li, Y.; Li, Z.; Zhu, H.; Zhu, W.; Wang, P.; Shi, Y. Qingfei litan decoction against acute lung injury/acute respiratory distress syndrome: The potential roles of anti-inflammatory and anti-oxidative effects. Front. Pharmacol., 2022, 13, 857502.
[http://dx.doi.org/10.3389/fphar.2022.857502] [PMID: 35677439]
[7]
Gao, P.; Zhao, Z.; Zhang, C.; Wang, C.; Long, K.; Guo, L.; Li, B. The therapeutic effects of traditional Chinese medicine Fusu agent in LPS-induced acute lung injury model rats. Drug Des. Devel. Ther., 2018, 12, 3867-3878.
[http://dx.doi.org/10.2147/DDDT.S181798] [PMID: 30518997]
[8]
Yang, Y.; Chen, J.; Ren, H.; Wei, L.; Huang, X.; Li, M.; Yuan, J.; Wang, L.; Jiang, X.; Guo, L.; Zhang, J. Protective effect of the eluting fraction of da-yuan-yin decoction on acute lung injury. Altern. Ther. Health Med., 2023, 29(5), 242-254.
[PMID: 37052973]
[9]
Yi, S.; Zou, L.; Li, Z.; Sakao, K.; Wang, Y.; Hou, D.X. In vitro antioxidant activity of areca nut polyphenol extracts on RAW264.7 cells. Foods, 2022, 11(22), 3607.
[http://dx.doi.org/10.3390/foods11223607] [PMID: 36429198]
[10]
Sarrica, A.; Kirika, N.; Romeo, M.; Salmona, M.; Diomede, L. Safety and toxicology of magnolol and honokiol. Planta Med., 2018, 84(16), 1151-1164.
[http://dx.doi.org/10.1055/a-0642-1966] [PMID: 29925102]
[11]
Dinda, B.; Dinda, S.; DasSharma, S.; Banik, R.; Chakraborty, A.; Dinda, M. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur. J. Med. Chem., 2017, 131, 68-80.
[http://dx.doi.org/10.1016/j.ejmech.2017.03.004] [PMID: 28288320]
[12]
Zhang, S.; Zhang, Q.; An, L.; Zhang, J.; Li, Z.; Zhang, J.; Li, Y.; Tuerhong, M.; Ohizumi, Y.; Jin, J.; Xu, J.; Guo, Y. A fructan from anemarrhena asphodeloides bunge showing neuroprotective and immunoregulatory effects. Carbohydr. Polym., 2020, 229, 115477.
[http://dx.doi.org/10.1016/j.carbpol.2019.115477] [PMID: 31826524]
[13]
Lin, Y.; Liu, Z.; Zhao, W.R.; Shi, W.T.; Zhang, J.; Zhang, K.Y.; Ding, Q.; Chen, X.L.; Tang, J.Y.; Zhou, Z.Y. Pharmacological activity, pharmacokinetics, and toxicity of timosaponin AIII, a natural product isolated from anemarrhena asphodeloides bunge:A review. Front. Pharmacol., 2020, 11, 764.
[http://dx.doi.org/10.3389/fphar.2020.00764] [PMID: 32581782]
[14]
Chen, X.; Liu, Z.; Meng, R.; Shi, C.; Guo, N. Antioxidative and anticancer properties of Licochalcone A from licorice. J. Ethnopharmacol., 2017, 198, 331-337.
[http://dx.doi.org/10.1016/j.jep.2017.01.028] [PMID: 28111219]
[15]
Sayre, C.L.; Alrushaid, S.; Davies, N.M.; Martinez, S.E. Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice. Res. Pharm. Sci., 2016, 11(5), 355-365.
[http://dx.doi.org/10.4103/1735-5362.192484] [PMID: 27920817]
[16]
Shang, Z.; Gao, Y.; Xue, Y.; Zhang, C.; Qiu, J.; Qian, Y.; Fang, M.; Zhang, X.; Sun, X.; Kong, X.; Gao, Y. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1. Phytomedicine, 2024, 123, 155183.
[http://dx.doi.org/10.1016/j.phymed.2023.155183] [PMID: 37992491]
[17]
Zeng, Y.; Zhao, H.; Zhang, T.; Zhang, C.; He, Y.; Du, L.; Zuo, F.; Wang, W. Lung-protective effect of Punicalagin on LPS-induced acute lung injury in mice. Biosci. Rep., 2022, 42(1), BSR20212196.
[http://dx.doi.org/10.1042/BSR20212196] [PMID: 35028666]
[18]
Zhao, Q.; Ren, X.; Song, S.Y.; Yu, R.L.; Li, X.; Zhang, P.; Shao, C.L.; Wang, C.Y. Deciphering the underlying mechanisms of formula le-cao-shi against liver injuries by integrating network pharmacology, metabonomics, and experimental validation. Front. Pharmacol., 2022, 13, 884480.
[http://dx.doi.org/10.3389/fphar.2022.884480] [PMID: 35548342]
[19]
Lu, S.; Sun, X.; Zhou, Z.; Tang, H.; Xiao, R.; Lv, Q.; Wang, B.; Qu, J.; Yu, J.; Sun, F.; Deng, Z.; Tian, Y.; Li, C.; Yang, Z.; Yang, P.; Rao, B. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation. Front. Immunol., 2023, 14, 1235575.
[http://dx.doi.org/10.3389/fimmu.2023.1235575] [PMID: 37799727]
[20]
Wu, F.; Wu, G.; Li, T.; Lu, W.; Fu, T.; Zhang, Z. Exploring the target and mechanism of radix paeoniae alba on sjogren’s syndrome. Comb. Chem. High Throughput Screen., 2023, 26(6), 1224-1232.
[http://dx.doi.org/10.2174/1386207325666220823144054] [PMID: 36017844]
[21]
Zhang, W.; Sun, M.; Lv, G.; Guo, W.; Hu, J.; Gu, J.; Wang, Y.; Gong, Q.; Pi, Z.; Lin, Z. Exploring the mechanism of tenghuang jiangu wan in osteoporosis treatment based on network pharmacology, molecular docking and experimental pharmacology. Chin. J. Anal. Chem., 2024, 52(1), 100351.
[http://dx.doi.org/10.1016/j.cjac.2023.100351]
[22]
Wang, J.; Li, H.; Yang, Z.; Huang, C.; Sun, Y.; Hu, X. Elucidation of the mechanisms and molecular targets of run-zao-zhiyang capsule for itch based on network pharmacology, molecular docking and In vitro Experiment. Comb. Chem. High Throughput Screen., 2023, 26(10), 1866-1878.
[http://dx.doi.org/10.2174/1386207326666221031115440] [PMID: 36321233]
[23]
Falah Alshehri, F.; Alzahrani, F.M.; Alkhoshaiban, A.; Saad Al Shehri, Z. Exploring the multi-gene regulatory molecular mechanism of Saudi Arabian flora against epilepsy based on data mining, network pharmacology and docking analysis. Saudi Pharm. J., 2023, 31(9), 101732.
[http://dx.doi.org/10.1016/j.jsps.2023.101732] [PMID: 37638220]
[24]
Qu, L.; Chen, C.; He, W.; Chen, Y.; Li, Y.; Wen, Y.; Zhou, S.; Jiang, Y.; Yang, X.; Zhang, R.; Shen, L. Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway. Am. J. Transl. Res., 2019, 11(4), 2042-2055.
[PMID: 31105816]
[25]
Kellner, M.; Noonepalle, S.; Lu, Q.; Srivastava, A.; Zemskov, E.; Black, S.M. ROS signaling in the pathogenesis of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Adv. Exp. Med. Biol., 2017, 967, 105-137.
[http://dx.doi.org/10.1007/978-3-319-63245-2_8] [PMID: 29047084]
[26]
Sweeney, R.M.; McAuley, D.F. Acute respiratory distress syndrome. Lancet, 2016, 388(10058), 2416-2430.
[http://dx.doi.org/10.1016/S0140-6736(16)00578-X] [PMID: 27133972]
[27]
Ward, P.A. Oxidative stress: Acute and progressive lung injury. Ann. N. Y. Acad. Sci., 2010, 1203(1), 53-59.
[http://dx.doi.org/10.1111/j.1749-6632.2010.05552.x] [PMID: 20716283]
[28]
Niu, X.; Wang, Y.; Li, W.; Mu, Q.; Li, H.; Yao, H.; Zhang, H. Protective effects of Isofraxidin against lipopolysaccharide-induced acute lung injury in mice. Int. Immunopharmacol., 2015, 24(2), 432-439.
[http://dx.doi.org/10.1016/j.intimp.2014.12.041] [PMID: 25596039]
[29]
Gao, J.; Wang, N.; Song, W.; Yuan, Y.; Teng, Y.; Liu, Z. Mechanisms underlying the synergistic effects of chuanxiong combined with Chishao on treating acute lung injury based on network pharmacology and molecular docking combined with preclinical evaluation. J. Ethnopharmacol., 2024, 325, 117862.
[http://dx.doi.org/10.1016/j.jep.2024.117862] [PMID: 38342157]
[30]
Zhou, W.; Hu, Z.; Wu, X.; Zhang, S.; Jiang, Y.; Tian, L.; Huang, X.; Ma, Z.; Qiu, L.; Zheng, P.; Zhang, S.; Lu, Z. Elucidation of the underlying mechanism of Hua-ban decoction in alleviating acute lung injury by an integrative approach of network pharmacology and experimental verification. Mol. Immunol., 2023, 156, 85-97.
[http://dx.doi.org/10.1016/j.molimm.2023.02.013] [PMID: 36913767]
[31]
Notarte, K.I.R.; Quimque, M.T.J.; Macaranas, I.T.; Khan, A.; Pastrana, A.M.; Villaflores, O.B.; Arturo, H.C.P.; Pilapil, D.Y.H., IV; Tan, S.M.M.; Wei, D.Q.; Wenzel-Storjohann, A.; Tasdemir, D.; Yen, C.H.; Ji, S.Y.; Kim, G.Y.; Choi, Y.H.; Macabeo, A.P.G. Attenuation of lipopolysaccharide-induced inflammatory responses through inhibition of the NF-κB pathway and the increased NRF2 level by a flavonol-enriched n -butanol fraction from Uvaria alba. ACS Omega, 2023, 8(6), 5377-5392.
[http://dx.doi.org/10.1021/acsomega.2c06451] [PMID: 36816691]
[32]
Quimque, M.T.; Notarte, K.I.; Letada, A.; Fernandez, R.A.; Pilapil, D.Y., IV; Pueblos, K.R.; Agbay, J.C.; Dahse, H.M.; Wenzel-Storjohann, A.; Tasdemir, D.; Khan, A.; Wei, D.Q.; Gose Macabeo, A.P. Potential cancer and alzheimer’s disease-targeting phosphodiesterase inhibitors from Uvaria alba: Insights from In vitro and consensus virtual screening. ACS Omega, 2021, 6(12), 8403-8417.
[http://dx.doi.org/10.1021/acsomega.1c00137] [PMID: 33817501]
[33]
Thomas Edison, E.D. Biomining fungal endophytes from tropical plants and seaweeds for drug discovery; Biodiver. Biomed, 2020, pp. 51-62.
[http://dx.doi.org/10.1016/B978-0-12-819541-3.00004-9]
[34]
dela Cruz, T.E.E.; Timbreza, L.P.; Sangvichien, E.; Notarte, K.I.R.; Santiago, K.A.A. Comparative study on the antimicrobial activities and metabolic profiles of five Usnea species from the philippines. J. Fungi, 2023, 9(11), 1117.
[http://dx.doi.org/10.3390/jof9111117] [PMID: 37998922]
[35]
Sun, Z.; Chen, A.; Fang, H.; Sun, D.; Huang, M.; Cheng, E.; Luo, M.; Zhang, X.; Fang, H.; Qian, G. B cell-derived IL-10 promotes the resolution of lipopolysaccharide-induced acute lung injury. Cell Death Dis., 2023, 14(7), 418.
[http://dx.doi.org/10.1038/s41419-023-05954-2] [PMID: 37443161]
[36]
Wang, K.; Wang, M.; Liao, X.; Gao, S.; Hua, J.; Wu, X.; Guo, Q.; Xu, W.; Sun, J.; He, Y.; Li, Q.; Gao, W. Locally organised and activated Fth1hi neutrophils aggravate inflammation of acute lung injury in an IL-10-dependent manner. Nat. Commun., 2022, 13(1), 7703.
[http://dx.doi.org/10.1038/s41467-022-35492-y] [PMID: 36513690]
[37]
Chang, H.Y.; Chen, Y.C.; Lin, J.G. Asatone prevents acute lung injury by reducing expressions of NF-KB,MAPK and inflammatory cytokines. Am. J. Chin. Med., 2018, 46(3), 651-671.
[http://dx.doi.org/10.1142/S0192415X18500349] [PMID: 29595073]
[38]
Imai, Y.; Kuba, K.; Neely, G.G.; Yaghubian-Malhami, R.; Perkmann, T.; van Loo, G.; Ermolaeva, M.; Veldhuizen, R.; Leung, Y.H.C.; Wang, H.; Liu, H.; Sun, Y.; Pasparakis, M.; Kopf, M.; Mech, C.; Bavari, S.; Peiris, J.S.M.; Slutsky, A.S.; Akira, S.; Hultqvist, M.; Holmdahl, R.; Nicholls, J.; Jiang, C.; Binder, C.J.; Penninger, J.M. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell, 2008, 133(2), 235-249.
[http://dx.doi.org/10.1016/j.cell.2008.02.043] [PMID: 18423196]
[39]
Ayala, A.; Muñoz, M.F.; Argüelles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev., 2014, 2014, 1-31.
[http://dx.doi.org/10.1155/2014/360438] [PMID: 24999379]
[40]
Kim, K.H.; Kim, D.H.; Jeong, N.; Kim, K.I.; Kim, Y.H.; Lee, M.; Choi, J.Y.; Jung, H.J.; Jung, S.K.; Joo, M. Therapeutic effect of Chung-Pae, an experimental herbal formula, on acute lung inflammation is associated with suppression of NF- κ B and activation of Nrf2. Evid. Based Complement. Alternat. Med., 2013, 2013, 1-11.
[http://dx.doi.org/10.1155/2013/659459] [PMID: 24062787]
[41]
Zhu, L.; Wei, M.; Yang, N.; Li, X. Glycyrrhizic acid alleviates the meconium-induced acute lung injury in neonatal rats by inhibiting oxidative stress through mediating the Keap1/Nrf2/HO-1 signal pathway. Bioengineered, 2021, 12(1), 2616-2626.
[http://dx.doi.org/10.1080/21655979.2021.1937445] [PMID: 34499011]
[42]
Berka, V.; Liu, W.; Wu, G.; Tsai, A.L. Comparison of oxygen-induced radical intermediates in iNOS oxygenase domain with those from nNOS and eNOS. J. Inorg. Biochem., 2014, 139, 93-105.
[http://dx.doi.org/10.1016/j.jinorgbio.2014.06.011] [PMID: 25016313]
[43]
Jiang, K.; Guo, S.; Yang, C.; Yang, J.; Chen, Y.; Shaukat, A.; Zhao, G.; Wu, H.; Deng, G. Barbaloin protects against lipopolysaccharide (LPS)-induced acute lung injury by inhibiting the ROS-mediated PI3K/AKT/NF-κB pathway. Int. Immunopharmacol., 2018, 64, 140-150.
[http://dx.doi.org/10.1016/j.intimp.2018.08.023] [PMID: 30173054]
[44]
Kondylis, V.; Kumari, S.; Vlantis, K.; Pasparakis, M. The interplay of IKK, NF ‐κB and RIPK 1 signaling in the regulation of cell death, tissue homeostasis and inflammation. Immunol. Rev., 2017, 277(1), 113-127.
[http://dx.doi.org/10.1111/imr.12550] [PMID: 28462531]
[45]
Zhou, B.; Weng, G.; Huang, Z.; Liu, T.; Dai, F. Arctiin prevents LPS-Induced acute lung injury via inhibition of PI3K/AKT signaling pathway in mice. Inflammation, 2018, 41(6), 2129-2135.
[http://dx.doi.org/10.1007/s10753-018-0856-x] [PMID: 30116933]
[46]
Afonina, I.S.; Zhong, Z.; Karin, M.; Beyaert, R. Limiting inflammation the negative regulation of NF-κB and the NLRP3 inflammasome. Nat. Immunol., 2017, 18(8), 861-869.
[http://dx.doi.org/10.1038/ni.3772] [PMID: 28722711]
[47]
Wang, L.; Li, Z.; Lu, T.; Su, L.; Mao, C.; Zhang, Y.; Zhang, X.; Jiang, X.; Xie, H.; Yu, X. The potential mechanism of Choulingdan mixture in improving acute lung injury based on HPLC–Q‐TOF–MS, network pharmacology and in vivo experiments. Biomed. Chromatogr., 2023, 37(10), e5709.
[http://dx.doi.org/10.1002/bmc.5709] [PMID: 37533317]
[48]
Zhu, H.; Wang, S.; Shan, C.; Li, X.; Tan, B.; Chen, Q.; Yang, Y.; Yu, H.; Yang, A. Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach. Respir. Res., 2021, 22(1), 188.
[http://dx.doi.org/10.1186/s12931-021-01781-1] [PMID: 34183011]
[49]
Meng, L.; Li, L.; Lu, S.; Li, K.; Su, Z.; Wang, Y.; Fan, X.; Li, X.; Zhao, G. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Mol. Immunol., 2018, 94, 7-17.
[http://dx.doi.org/10.1016/j.molimm.2017.12.008] [PMID: 29241031]
[50]
Pooladanda, V.; Thatikonda, S.; Bale, S.; Pattnaik, B.; Sigalapalli, D.K.; Bathini, N.B.; Singh, S.B.; Godugu, C. Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation. Cell Death Dis., 2019, 10(2), 81.
[http://dx.doi.org/10.1038/s41419-018-1247-9] [PMID: 30692512]
[51]
Zhang, C.; Li, X.; Gao, D.; Zhu, H.; Wang, S.; Tan, B.; Yang, A. Network pharmacology and experimental validation of the anti-inflammatory effect of tingli dazao xiefei decoction in acute lung injury treatment. J. Inflamm. Res., 2023, 16, 6195-6209.
[http://dx.doi.org/10.2147/JIR.S433840] [PMID: 38145012]

Rights & Permissions Print Cite
Article Metrics
21
2
Wayfinder Image
© 2025 Bentham Science Publishers | Privacy Policy